Ryan Engel
Experienced in Leukocytosis

Dr. Ryan Engel

Hematology | Oncology
1221 N Highland Ave 1st Fl, 
Aurora, IL 
On Staff At
Experienced in Leukocytosis
1221 N Highland Ave 1st Fl, 
Aurora, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Ryan Engel is a Hematologist and an Oncologist in Aurora, Illinois. Dr. Engel is rated as an Experienced provider by MediFind in the treatment of Leukocytosis. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Inflammatory Breast Cancer, and Paget Disease of the Breast.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Residency
Advocate Lutheran General Hospital, Internal Medicine
Specialties
Hematology
Oncology
Licenses
Internal Medicine in WI
Board Certifications
American Board Of Internal Medicine, Hematology
Fellowships
McGaw Medical Center of Northwestern University, Hematology/Oncology
Hospital Affiliations
Advocate Christ Hospital & Medical Center
Advocate Good Samaritan Hospital
Javon Bea Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Celtic
  • HMO
  • INSURANCE PLAN
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MercyCare
  • EPO
  • HMO
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
MetLife
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

Advocate Infusion Center
1221 N Highland Ave 1st Fl, Aurora, IL 60506

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: October 09, 2025
Intervention Type: Other, Radiation, Procedure, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3

1 Total Publications

Evaluation of α-hydroxycinnamic acids as pyruvate carboxylase inhibitors.
Evaluation of α-hydroxycinnamic acids as pyruvate carboxylase inhibitors.
Journal: Bioorganic & medicinal chemistry
Published: May 04, 2019
Similar Doctors
Distinguished in Leukocytosis
Dr. Nida Hussain
Hematology | Oncology
Distinguished in Leukocytosis
Dr. Nida Hussain
Hematology | Oncology
4405 Weaver Pkwy, 
Waterman, IL 
 (8.0 miles away)
815-334-5566
Experience:
12+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Nida Hussain is a Hematologist and an Oncologist in Waterman, Illinois. Dr. Hussain has been practicing medicine for over 12 years and is rated as an Advanced provider by MediFind in the treatment of Leukocytosis. Her top areas of expertise are Leukocytosis, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Large-Cell Lung Carcinoma.

Katy H. Goldsborough
Distinguished in Leukocytosis
Dr. Katy H. Goldsborough
Hematology | Oncology
Distinguished in Leukocytosis
Dr. Katy H. Goldsborough
Hematology | Oncology

Advocate Good Samaritan Cancer Center

3745 Highland Ave 2nd Fl, 
Downers Grove, IL 
 (15.8 miles away)
630-275-2300
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Katy Goldsborough is a Hematologist and an Oncologist in Downers Grove, Illinois. Dr. Goldsborough is rated as an Advanced provider by MediFind in the treatment of Leukocytosis. Her top areas of expertise are Breast Cancer, Leukocytosis, Paget Disease of the Breast, and Pleuropulmonary Blastoma.

Habib Shaikh
Advanced in Leukocytosis
Dr. Habib Shaikh
Hematology | Oncology
Advanced in Leukocytosis
Dr. Habib Shaikh
Hematology | Oncology
304 Randall Rd, 
Geneva, IL 
 (7.3 miles away)
630-208-4060
Experience:
21+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Habib Shaikh is a Hematologist and an Oncologist in Geneva, Illinois. Dr. Shaikh has been practicing medicine for over 21 years and is rated as a Distinguished provider by MediFind in the treatment of Leukocytosis. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Non-Hodgkin Lymphoma, Leukocytosis, and Familial Prostate Cancer.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Engel's expertise for a condition
ConditionClose
    View All 23 Advanced Conditions
    View All 114 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile